Using TreeScan as a Signal Identification Approach to Screen for Adverse Maternal Outcomes of Medication Use in Pregnancy

This presentation examines the performance of the TreeScan signal identification method in identifying signals for material and obstetric adverse outcomes occurring from 20 weeks gestation to 30 days post-delivery among women with live births that are exposed to oral macrolides compared to oral penicillins. It was presented at the International Society for Pharmacoepidemiology's Student Webinar on August 9, 2022.